Table 5.
The results of the two groups on the further efficacy and safety variables.
| Treatment group | Control group | p value | |
|---|---|---|---|
| (n = 47) | (n = 44) | ||
| SBP (mmHg) | 119.00 (115.00, 127.00)∗ | 119.00 (109.25, 127.00)∗ | 0.415 |
| DBP (mmHg) | 78.00 (75.00, 80.00)∗ | 76.00 (72.00, 80.00)∗ | 0.111 |
| HbA1c (%) | 7.67 ± 0.24∗ | 7.50 ± 0.20∗ | 0.066 |
| AST (μ/L) | 20.00 (16.00, 25.00) | 18.50 (16.00, 23.75) | 0.650 |
| ALT (μ/L) | 18.0 (14.00, 26.00) | 19.50 (15.25, 24.50) | 0.827 |
| BUN (mmol/L) | 5.19 ± 0.18 | 5.13 ± 0.24 | 0.832 |
| Scr (μmol/L) | 63.00 (56.00, 75.00) | 62.00 (54.25, 80.75) | 0.921 |
| HDL (mmol/L) | 1.23 (1.11, 1.46) | 1.20 (0.99, 1.65) | 0.586 |
| LDL (mmol/L) | 2.58 ± 0.10∗ | 2.77 ± 0.16∗ | 0.296 |
| TG (mmol/L) | 1.22 (0.87, 1.56)∗ | 1.14 (0.53, 1.80)∗ | 0.984 |
| TC (mmol/L) | 4.44 ± 0.13∗ | 4.67 ± 0.17∗ | 0.136 |
Data are expressed as the mean ± SD for normal distribution. Nonnormally distributed values are presented as median (interquartile range). p values represent the treatment group versus the control group. ∗ represent p < 0.05 versus baseline (week 0), paired t-test for normal distribution or Wilcoxon matched-pairs signed-rank test for nonnormal distribution. SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate transaminase. ALT, alanine transaminase; BUN, blood urea nitrogen; Scr, serum creatinine; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; TG, triglycerides; TC, total cholesterol.